127
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells

, , , , , , , , , & show all
Pages 2207-2218 | Published online: 27 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yu Xia, Guoyi Tang, Changbing Wang, Jiayu Zhong, Yi Chen, Liang Hua, Yinghua Li, Hongsheng Liu & Bing Zhu. (2020) Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer. Drug Delivery 27:1, pages 15-25.
Read now

Articles from other publishers (16)

Jiale Ju, Yinghua Wu, Wen He, Lin Zhan, Xuelian Yin, Junfeng Zhang, Yuxi Zhang, Li Qiu, Pir Muhammad, Rui L. Reis & Chenchen Li. (2022) Nanocarriers for Active Ingredients of Chinese Medicine (AIFCM) Used in Gastrointestinal Cancer Therapy. Journal of Biomedical Nanotechnology 18:10, pages 2279-2314.
Crossref
Yuan Zhong, Yanan Gai, Jiajia Gao, Weifen Nie, Zhenzhen Bao, Weiqi Wang, Xiaoqing Xu, Jie Wu & Yuedong He. (2022) Selection and validation of reference genes for quantitative real-time PCR normalization in Psoralea corylifolia (Babchi) under various abiotic stress. Journal of Plant Physiology 274, pages 153722.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh & Gorka Orive. (2022) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 27:2, pages 436-455.
Crossref
Ayeskanta Mohanty, Saji Uthaman & In-Kyu Park. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers 319 349 .
Letícia Bueno Macedo, Daniele Rubert Nogueira-Librelotto, Daniela Mathes, Josiele Melo de Vargas, Raquel Mello da Rosa, Oscar Endrigo Dorneles Rodrigues, Maria Pilar Vinardell, Montserrat Mitjans & Clarice Madalena Bueno Rolim. (2021) Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound—An In Vitro Study. Pharmaceutics 14:1, pages 80.
Crossref
Zhaojuan Guo, Pin Li, Chunguo Wang, Qianjun Kang, Can Tu, Bingqian Jiang, Jingxuan Zhang, Weiling Wang & Ting Wang. (2021) Five Constituents Contributed to the Psoraleae Fructus-Induced Hepatotoxicity via Mitochondrial Dysfunction and Apoptosis. Frontiers in Pharmacology 12.
Crossref
Danhui Zhao, Lanhui Wang, Kun-ze Du, Evans Owusu Boadi, Jin Li, Fei Tian & Yan-xu Chang. (2021) A sustainable vortex-assisted matrix solid phase dispersion for the simultaneous extraction of five active components from Saposhnikoviae Radix. Sustainable Chemistry and Pharmacy 24, pages 100524.
Crossref
Fengjie Liu, Lihong Li, Meng Lan, Tengteng Zou, Zhaodi Kong, Tiange Cai, Xiaoyu Wu & Yu Cai. (2021) Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer. Nanomedicine 16:27, pages 2411-2430.
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Laís E. Scheeren, Daniele R. Nogueira-Librelotto, Daniela Mathes, Micheli M. Pillat, Letícia B. Macedo, Montserrat Mitjans, M. Pilar Vinardell & Clarice M.B. Rolim. (2021) Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells. Toxicology in Vitro 75, pages 105192.
Crossref
Rishi Paliwal, Shivani Rai Paliwal & Rameshroo Kenwat. 2021. Nano Drug Delivery Strategies for the Treatment of Cancers. Nano Drug Delivery Strategies for the Treatment of Cancers 319 339 .
Ayeskanta Mohanty, Saji Uthaman & In-Kyu Park. (2020) Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules 25:19, pages 4377.
Crossref
Xiaoqin Chi, Kun Liu, Xiangjie Luo, Zhenyu Yin, Hongyu Lin & Jinhao Gao. (2020) Recent advances of nanomedicines for liver cancer therapy. Journal of Materials Chemistry B 8:17, pages 3747-3771.
Crossref
Yu Xia, Guoyi Tang, Min Guo, Tiantian Xu, Haiyang Chen, Zhengfang Lin, Yinghua Li, Yi Chen, Bing Zhu, Hongsheng Liu & Jie Cao. (2020) Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo. Materials Science and Engineering: C 110, pages 110594.
Crossref
Yao Liu, Wei Liu, Sha Xiong, Jingshan Luo, Ye Li, Yuying Zhao, Qun Wang, Zexin Zhang, Xiaojia Chen & Tongkai Chen. (2020) Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson’s disease. International Journal of Pharmaceutics 577, pages 119053.
Crossref
Gong‐En Tang, Yue‐Xiang Niu, Yun Li, Chao‐Yu Wu, Xiao‐Ying Wang & Jian Zhang. (2019) Paris saponin VII enhanced the sensitivity of HepG2/ADR cells to ADR via modulation of PI3K/AKT/MAPK signaling pathway. The Kaohsiung Journal of Medical Sciences 36:2, pages 98-106.
Crossref